Ameriprise’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
Other funds holding ULBI
VWA
VCM
THC
RC
Ameriprise's ULBI Position: Q1 2026 in Review
Ameriprise reduced its Ultralife (ULBI) stake by 1.2% in Q1 2026, selling an estimated $2.75K and leaving 36,150 shares worth $236K. The position accounts for ﹤0.01% of the portfolio, ranked #3826.
Ameriprise first reported a position in ULBI in Q2 2025 and has held it in 4 quarters since. The position peaked at $331K in Q2 2025. 50 funds tracked by Wall St. Rank hold ULBI as of Q1 2026.
- Ameriprise held 36,150 shares of Ultralife worth $236K as of Q1 2026.
- Ameriprise sold 442 Ultralife shares in Q1 2026, an estimated $2.75K.
- Ultralife made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3826 holding.
- Ameriprise first reported a position in Ultralife in Q2 2025 and has held it in 4 quarters since.
- Ameriprise's Ultralife position peaked at $331K in Q2 2025.
- 50 funds tracked by Wall St. Rank held Ultralife as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.